Cargando…

Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis

Nutrient overload and genetic factors have led to a worldwide epidemic of obesity that is the underlying cause of diabetes, atherosclerosis, and cardiovascular disease. In this study, we used macrolide drugs such as FK506, rapamycin, and macrolide derived, timcodar (VX-853), to determine their effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinds, Terry D., John, Kezia, McBeth, Lucien, Trabbic, Christopher J., Sanchez, Edwin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848453/ https://www.ncbi.nlm.nih.gov/pubmed/27190501 http://dx.doi.org/10.1155/2016/6218637

Ejemplares similares

Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017)

Bilirubin Binding to PPARα Inhibits Lipid Accumulation
por: Stec, David E., et al.
Publicado: (2016)

Prostaglandins as PPARγ Modulators in Adipogenesis
por: Fujimori, Ko
Publicado: (2012)

Transcriptional and epigenetic regulation of PPARγ expression during adipogenesis
por: Lee, Ji-Eun, et al.
Publicado: (2014)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

Osterix represses adipogenesis by negatively regulating PPARγ transcriptional activity
por: Han, Younho, et al.
Publicado: (2016)

STK38 is a PPARγ-interacting protein promoting adipogenesis
por: Qian, Kun, et al.
Publicado: (2021)

FKBP5 activates mitophagy by ablating PPAR-γ to shape a benign remyelination environment
por: Sun, Xingzong, et al.
Publicado: (2023)

Sweet-P inhibition of glucocorticoid receptor β as a potential cancer therapy
por: Nwaneri, Assumpta C., et al.
Publicado: (2016)

Nuclear Receptor Cofactors in PPARγ-Mediated Adipogenesis and Adipocyte Energy Metabolism
por: Powell, Emily, et al.
Publicado: (2007)

Rock signaling control PPARγ expression and actin polymerization during adipogenesis
por: Ji, Yuntao, et al.
Publicado: (2017)

Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer
por: McBeth, Lucien, et al.
Publicado: (2015)

Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
por: Pillai, Hari K., et al.
Publicado: (2014)

A proline-type fullerene derivative inhibits adipogenesis by preventing PPARγ activation
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2016)

Erratum: “The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An in Vitro Study”
por: Hall, Julie M., et al.
Publicado: (2019)

MiR-19 Family Impairs Adipogenesis by the Downregulation of the PPARγ Transcriptional Network
por: Juiz-Valiña, Paula, et al.
Publicado: (2022)

Microfibrillar-associated protein 5 suppresses adipogenesis by inhibiting essential coactivator of PPARγ
por: Zhang, Tianlong, et al.
Publicado: (2023)

T-Cell Death-Associated Gene 51 Is a Novel Negative Regulator of PPARγ That Inhibits PPARγ-RXRα Heterodimer Formation in Adipogenesis
por: Kim, Sumi, et al.
Publicado: (2021)

De-Novo Identification of PPARγ/RXR Binding Sites and Direct Targets during Adipogenesis
por: Hamza, Mohamed Sabry, et al.
Publicado: (2009)

Regulation of adipogenesis by nuclear receptor PPARγ is modulated by the histone demethylase JMJD2C
por: Lizcano, Fernando, et al.
Publicado: (2011)

Coordinated Regulation of PPARγ Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity
por: Eeckhoute, Jérôme, et al.
Publicado: (2012)

TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPARγ2
por: Ho Lee, Jun, et al.
Publicado: (2015)

Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis
por: Liu, Chang, et al.
Publicado: (2015)

PPARγ Controls Ectopic Adipogenesis and Cross-Talks with Myogenesis During Skeletal Muscle Regeneration
por: Dammone, Gabriele, et al.
Publicado: (2018)

Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPARγ/RXR Heterodimerization
por: Hu, Jiamiao, et al.
Publicado: (2018)

Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells
por: Milton, Flora A., et al.
Publicado: (2017)

Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARγ expression
por: Xue, Peng, et al.
Publicado: (2019)

Structural Basis for the Inhibition of the Autophosphorylation Activity of HK853 by Luteolin
por: Zhou, Yuan, et al.
Publicado: (2019)

Correction to Lancet Rheumatol 2022; 4: e853–63
Publicado: (2023)

Structural investigation of ginsenoside Rf with PPARγ major transcriptional factor of adipogenesis and its impact on adipocyte
por: Siraj, Fayeza Md, et al.
Publicado: (2015)

Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis
por: Liu, Chang, et al.
Publicado: (2015)

CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis
por: Jang, Min Jun, et al.
Publicado: (2017)

Apigetrin inhibits adipogenesis in 3T3-L1 cells by downregulating PPARγ and CEBP-α
por: Hadrich, Fatma, et al.
Publicado: (2018)

Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity
por: Feng, Shi, et al.
Publicado: (2016)

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
por: Brusotti, Gloria, et al.
Publicado: (2017)

FKBP51 and Cyp40 are Positive Regulators of Androgen-dependent Prostate Cancer Cell Growth and the Targets of FK506 and Cyclosporin A
por: Periyasamy, Sumudra, et al.
Publicado: (2009)

Gsα signalling suppresses PPARγ2 generation and inhibits 3T3L1 adipogenesis
por: Zhang, Lei, et al.
Publicado: (2009)

Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARγ expression and phosphorylation
por: Wu, Ling, et al.
Publicado: (2010)

Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity
por: Mayoral, Rafael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5gvlkpg6663fvc583v1fbrs1a